A short- and long-term follow-up study of intersphincteric NASHA Dx implants for fecal incontinence.

ABSTRACT:

Background

The bulking agent NASHA Dx injected into the submucosal layer is effective in the treatment of fecal incontinence (FI) at short-and medium-term follow-up but efficacy after injection in the intersphincteric location is unknown. The aim of this study was to determine the short- and long-term efficacy and safety of NASHA Dx injected into the intersphincteric location for FI.

Methods

Patients were recruited from referrals to our Department for treatment of FI in November 2008-January 2010. Eligible patients were injected with 8 ml of NASHA Dx. Patients with a subtotal treatment effect were retreated after 2-4 weeks. The change in number of fecal incontinence episodes, the proportion of responders defined as at least 50% decrease in number of FI episodes and side effe

SUBMITTER: Ezra E 

PROVIDER: S-EPMC9458585 | biostudies-literature | 2022 Oct

REPOSITORIES: biostudies-literature